DM has been linked to a higher risk of severe complications and increased hospitalization, with pre-existing conditions in DM patients, such as endothelial dysfunction and a prothrombotic state, amplifying RAGE signaling, worsening lung inflammation, and thus increasing COVID-19 mortality [190]. This evidence concerns the gene AGER and COVID-19.